The present invention relates to the two enantiomers of a SElective Glucocorticoid Receptor Agonistic Modulator (SEGRAM) of Formula 1 or a derivative thereof; to a deuterated form of a SEGRAM of Formula 1 or a derivative thereof; and to the two deuterated enantiomers of a SEGRAM of Formula 1 or a derivative thereof:
or a pharmaceutically acceptable salt, solvate and/or prodrug thereof.
The present invention also relates to a SEGRAM of Formula 1 or a derivative thereof, or a pharmaceutically acceptable enantiomer, deuterated form, salt, solvate and/or prodrug thereof, for use in the prevention or treatment of an inflammatory disorder in a subject in need thereof.
本发明涉及式 1 的
SElective Glucocorticoid Receptor Agonistic Modulator(
SEGR
AM)的两种对映体或其衍
生物;涉及式 1 的
SEGR
AM 的一种氚代形式或其衍
生物;以及涉及式 1 的
SEGR
AM 的两种氚代对映体或其衍
生物:
或其药学上可接受的盐、溶液剂和/或原药。
本发明还涉及一种式1的
SEGR
AM或其衍
生物,或其药学上可接受的对映体、
氘代形式、盐、溶液剂和/或原药,用于预防或治疗有需要的受试者的炎症性疾病。